In October 2026, China National Medical Products Administration (NMPA) announced that 45 batches of cosmetics had been found non-compliant. The medical products administrations of Qinghai and Shandong provinces successively issued announcements on cosmetics supervision sampling inspections, with a cumulative total of 18 batches of cosmetics found non-compliant.
In addition, 8 enterprises were found to have serious defects in their production quality management systems. CIRS Group has now compiled and summarized the October sampling data and regulatory updates, so as to help enterprises keep abreast of market supervision trends and screen for compliance risks in advance.
China NMPA Cosmetics Supervision Sampling Data
NMPA Announcement on 45 Batches of Non-Compliant Cosmetics (No. 36 of 2026)
On October 15, 2026, the NMPA released the announcement that, in the 2026 national cosmetics sampling inspections, 45 batches of cosmetics were found non-compliant upon inspection by the Tianjin Institute for Drug Control and other institutions. The non-compliant products included face masks, toothpastes, sunscreen lotions, body washes, etc. The non-compliant items included excessive total bacterial count; and the non-detection of the sunscreen agents indicated in the technical requirements stated on the product labels and registration materials, such as 4-methylbenzylidene camphor, octocrylene, and ethylhexyl methoxycinnamate.
Local Medical Products Administrations' Cosmetics Supervision Sampling Data
Announcement by the Qinghai Medical Products Administration on Cosmetics Supervision Sampling Information in 2026
On October 28, 2026, the Qinghai Medical Products Administration released the announcement that, in 2026, the provincial administration organized quality sampling inspections of cosmetics across the whole province, covering a total of 202 batches of cosmetics, of which 193 batches were compliant and 9 batches were non-compliant. The non-compliant products included 3 batches of spot-fading products, 2 batches of toothpastes, 2 batches of sunscreen lotions, 1 batch of body wash, and 1 batch of shampoo. The non-compliant items included the detection of the prohibited ingredient mercury; excessive total bacterial count; and the non-detection of the sunscreen agents indicated in the technical requirements stated on the product labels and registration materials, such as ethylhexyl salicylate.
Announcement by the Shandong Medical Products Administration on the Results of Cosmetics Sampling Inspections
On October 29, 2026, the Shandong Medical Products Administration released the announcement that the provincial administration had organized cosmetics sampling inspections across the whole province, covering hair dye products, general skincare products, perfumes, whitening and spot-fading products, face masks, sunscreens, etc. The inspections found 9 batches of products non-compliant. The non-compliant items included the detection of the prohibited ingredients trans-2-heptenal and metronidazole; excessive total bacterial count; and the detection of the sunscreen agents not indicated in the technical requirements stated in the filing materials, such as ethylhexyl methoxycinnamate.
Regulatory Updates
Announcement by the Jiangsu Medical Products Administration on Cosmetics Supervision Inspections (No. 12 of 2026)
On October 7, 2026, the Jiangsu Medical Products Administration released the announcement that the provincial administration had recently conducted on-site for-cause inspections of some cosmetics manufacturers in the province, and found that 3 enterprises in production had 'serious defects in their production quality management systems'. The Jiangsu administration has taken risk control measures against the above enterprises in accordance with the law, such as ordering them to suspend production.
Announcement by the Zhejiang Medical Products Administration on Cosmetics Supervision Inspections in 2026 (Issue No. 1)
On October 8, 2026, the Zhejiang Medical Products Administration released the announcement that the provincial administration had earlier organized supervision inspections of 25 cosmetics registrants, notifiers, and entrusted manufacturers in the province, and found that 5 enterprises had serious defects in their production quality management systems. Among them, 4 enterprises completed rectification and had their cases closed; 1 enterprise whose case had been closed had deregistered its registrant/notifier account.
CIRS Reminder
The results of cosmetics regulatory sampling inspections across many regions of China in October 2026 show that problems such as excessive microbial content, illegal addition of prohibited ingredients, and inconsistent ingredient comparison are relatively concentrated. Meanwhile, problems such as inadequate implementation of compliance management by business operators still exist in the market.
CIRS hereby reminds relevant enterprises to keep a close eye on industry regulatory trends, carry out raw material control and formula review against the typical problems identified in sampling inspections, and screen for potential compliance risks in a timely manner. Enterprises should strictly abide by the Cosmetics Supervision and Administration Regulation and relevant technical standards, so as to avoid quality problems and compliance risks at the source and comprehensively build a solid bottom line of quality safety and compliance.
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.
Our Services
- China Cosmetics Registration and Filing
- China New Cosmetic Ingredients Registration and Filing
- China Toothpaste Filing
- China Cosmetics Safety and Efficacy Test
- Being Domestic Responsible Person
- Safety Evaluation Report
- Cosmetic Ingredient Quality
- Formula/Label/Ingredient Review
- Regulatory Consulting/Reporting/Training
- Custom Clearance



